Researchers see benefits, little risk from renal denervation

10/29/2012 | MedPage Today

The use of renal nerve ablation to treat refractory high blood pressure appears to carry long-term benefits with little risk of adverse events, according to researchers from Australia's Baker Heart and Diabetes Institute in Melbourne who reported the findings at TCT 2012. Within a month, 69% of patients demonstrated a response to the treatment, and at the three-year mark, 94% of remaining study participants had responded.

View Full Article in:

MedPage Today

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Assistant General Counsel, Regulatory
Cardinal Health
Waukegan, IL
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations